KCNK1 and metastatic malignant neoplasm in the lymph nodes: Further analysis showed that KCNK1 was positively associated with clinical stage, lymph node metastasis, poor overall survival, and poor relapse-free survival in breast cancer patients (Fig 1B and 1C).